产品编号:M425030
产品规格:10mg
产品价格:面议
| 标准品编号: | M425030 |
| 名称: | MK-2048 |
| 别名: | (6S)-2-(3-Chloro-4-fluorobenzyl)-8-ethyl-10-hydroxy-N,6-dimethyl-1,9-dioxo-1,2,6,7,8,9-hexahydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide; |
| CAS号: | 869901-69-9 |
| 分子式: | C₂₁H₂₁ClFN₅O₄ |
| 外观: | Yellow Solid |
| 熔点: | >240°C (dec.) |
| 分子量: | 461.87 |
| 储存: | -20°C Freezer |
| 溶解度: | DMSO (Slightly), Methanol (Slightly) |
| 种类: | Research Tools; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | MK-2048 represents a prototype second generation integrase strand transfer inhibitor (INSTI), it was developed with the goal of retaining activity against viruses containing mutations assiciated with resistance of first-generation INSTIs, raltegravir (R100312). MK-2048 exhibits inhibitory activity towards HIV integrase and towards HIV replication. It is four times more effective in inhibiting HIV enzyme integrase than the first generation inhibitor, raltegravir. |
| 参考文献 | |